NEW YORK--(BUSINESS WIRE)-via Yahoo finance - -Reportlinker.com announces that a new market research report is available in its catalogue.
Multiple Sclerosis Treatment Market: Opportunities for Oral Drugs
http://www.reportlinker.com/p0109873/Multiple-Sclerosis-Treatment-Market-Opportunities-for-Oral-Drugs.html
Only about 36% of Multiple Sclerosis (MS) patients are currently treated with MS drugs, this percentage is expected to increase to 56% by 2014 as new oral MS therapies are launched, which shows bright opportunity for oral drugs in multiple sclerosis market. The injectables market is big but leaves certain side effects which bring the possibility for the oral drugs to succeed. It is expected that oral drugs will bring some ease for the patients. In Canada the prevalence rate of MS is the highest with closely followed by United States which is the second most affected region with increasing death rates of MS patients. Also the prevalence rate in Germany, Norway and Hungary is high. In 2008 the MS treatment market has shown good results despite the slowdown in US and with this success the probability for further growth has increased. .
Please return here to leave your comments. Thank You
============================================
0 comments:
Post a Comment